Structural
Tricuspid/Pulmonic Valve Intervention Learning Series
TTV-Replacement - Indications, Devices and Outcomes
TTV-Replacement - Indications, Devices and Outcomes
Episodes
Lead-Induced TR and Conduction Abnormalities in TTVI: When to Extract?
5 min.
Lead-Induced TR and Conduction Abnormalities in TTVI: When to do TTVR?
15 min.
LIVE Case Presentation: St. Michael’s Hospital, Toronto, Canada
60 min.
Live Pre-Recorded Case Presentation 1: TTVR (Intrepid) - Montefiore Medical Center, New York, NY
33 min.
MonarQ TTVR System: Technology Update and Early Clinical Experience
10 min.
Topaz TTVR System: EFS and EU PIVOTAL Study Results
9 min.
Trisol TTVR System: EFS Update
9 min.
Laplace TTVR System: EFS Update
12 min.
Lux TTVR System: Global Clinical Experience and EFS Update
11 min.
Cardiovalve TTVR: Technology and Clinical Program Update
8 min.
Patient Selection for TTVR: Clinical/Physiologic Considerations
13 min.
Patient Selection for TTVR: Imaging Considerations
13 min.
Intra-Procedural Imaging Step-by-Step: Simulation Training
10 min.
The Impact of Preprocedural Optimization: Maximizing TTVI Outcomes
18 min.
Enhancing TTVI Safety: Strategies to Minimize Bleeding Complications
17 min.
Right Heart Failure After TTVI: Early Detection and Treatment
16 min.
Thrombosis and HALT in TTVR: Knowns, Unknowns, and Clinical Implications
9 min.
Case Presentation: TTVR (LUX) - Montefiore Medical Center, New York, NY
30 min.
Presentation 1: TRISOL TTVR - Piedmont Heart Institute, Atlanta, GA
14 min.
Presentation 2: LAPLACE TTVR - Piedmont Heart Institute, Atlanta, GA
16 min.
The Mis(t)ery of Right Heart Failure in Tricuspid Regurgitation: Pre- and Post-Intervention: Does Right Heart Ventricular Function Impact Device Choices in TTVI?
5 min.
What Is the Role of Heterotopic Valves for Refractory TR Patients
7 min.
EVOQUE System Overview & TRISCEND II Data
7 min.
Early Outcomes of Real-World TTVR (Evoque)
12 min.
Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial
12 min.
Post-TTVR Function: Normal or Abnormal
21 min.
TTVR Patient Selection: Who Benefits, Who Doesn't, and What Challenges Remain
14 min.
Bridging the Gaps: Key Takeaways from TRISCEND II
14 min.
Second Generation TTVR Technologies to the Rescue
15 min.
TTVR: Expanding Clinical Indications and Future Trials
15 min.
At the End of the Road: Caval Valves in Advanced TR Patients?
9 min.
30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial
14 min.
Right Heart Remodeling Following TTVR With the VDyne System: Results From the VISTA EFS Program
11 min.
TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation
25 min.
TRISCEND II Trial: Editorial Commentary
12 min.
TCT 1285: Simultaneous Combined Procedure of Edge-to-Edge Transcatheter Mitral Repair (M-TEER) and Heterotopic Transcatheter Tricuspid Valve Replacement for Complex Multivalvular Disease
8 min.
Here We Grow! What Do Teams Need to Know about the Current and Future State of Tricuspid Therapies?
23 min.
TCT 1247: A Novel TTVR System in a Patient Presenting With Challenging Right Heart Anatomy
6 min.
TCT 1386: Taking the High Road: A Challenging Transcatheter Tricuspid Valve Replacement
13 min.
TCT 1406: Transcatheter Tricuspid Valve Replacement via Jugular Access Using Edwards Certitude System
5 min.
What Is the Future of Percutaneous Tricuspid Valve Procedures? Focus on ACHD
15 min.
Case Presentation 2: Tricuspid Replacement with the Evoque Valve
10 min.
Topline Results from the TRISCEND II Transcatheter Tricuspid Valve Replacement Trial
14 min.
Is That in My Way? The Interventional Cardiologist's Perspective
17 min.
Extract or Go to Jail: CIED Lead Management in Patients Undergoing Tricuspid Valve Intervention
14 min.
Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention
15 min.
Case Resolution: Case of TTVI in Lead-induced: TR Assessment and Management
4 min.
Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!
6 min.
Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!
11 min.
Case Presentation: TTVI in the Failing Right Heart
3 min.
Case Resolution: TTVI in the Failing Right Heart
9 min.
Case Presentation: TTVI in Patients with Large Gaps
3 min.
TTVI in Patients with Large Gaps/Tethering
5 min.
Case Resolution: TTVI in Patients with Large Gaps
4 min.
Case Presentation: Case of TTVI in Lead-induced: TR Assessment and Management
2 min.
TTVI in Lead Induced TR: Assessment and Management
12 min.
Transcatheter Tricuspid Valve Replacement - TRISCEND II
7 min.
Assessing Functional Status and Predicting Clinical Improvement
7 min.
Walking the Tightrope: Bleeding vs Thrombosis Risk Following Transcatheter Tricuspid Valve Replacement
7 min.
RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options
14 min.
Live Case: LUX Tricuspid Valve Replacement – St. Michael's Hospital, Toronto, Canada
30 min.
Case-in-Box - Cardiovalve
15 min.
Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement
16 min.
Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?
12 min.
Live-in-a-Box TTVR Case with Emphasis on Intraprocedural Imaging
17 min.
A Concise Overview of Right Heart Physiology and Relevance to TR Management
10 min.
Lead Management Considerations in TR Patients
6 min.
Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR
5 min.
TRISCEND II: Understanding the Study Design and Interpreting the Results
8 min.
Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?
15 min.
Incidence, Predictors, and Management of Conduction Disturbances After Transcatheter Tricuspid Valve Replacement: The TRIPLACE Registry
16 min.
EVOQUE System and the TMTT Portfolio
20 min.
Case Resolution: A Non-Surgical Patient With Complex Tricuspid Valve Disease
8 min.
What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly
13 min.
Patient Selection in Transcatheter Tricuspid Valve Replacement: How to Best Use Multimodality Imaging?
15 min.
Pre-Existing and New CIED: The Achilles Heel of Transcatheter Tricuspid Valve Replacement?
15 min.
Lifetime Management of Transcatheter Tricuspid Valve Replacement: Patient and Device Considerations
13 min.
Case Presentation: A Non-Surgical Patient With Complex Tricuspid Valve Disease
4 min.
Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes
7 min.
Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives
15 min.
Case Discussion: Severe Tricuspid Regurgitation in Right Heart Failure and Severe Tricuspid Regurgitation
21 min.
Case Resolution: Severe Tricuspid Regurgitation in Right Heart Failure and Severe Tricuspid Regurgitation
6 min.
Orthotopic TTVR: What Have We Learned From the EFS studies
14 min.
Next Generation TTVR: Overview of Devices and Current Status
9 min.
Who Are the TTVR Patients We Are Treating and What Are the Challenges?
9 min.
Leaflet Thrombosis and HALT: The Achilles Heel of TTVR?
6 min.
Why TTVR Over TEER: Anatomic and Clinical Considerations
10 min.
Heterotopic TTVR: Clinical Updates and Device Overviews
10 min.
Keynote Lecture: Patient Selection for Transcatheter Tricuspid Valve Interventions: Imaging and Clinical Drivers
18 min.
TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation
22 min.
One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study
9 min.
A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results
7 min.
TMVR vs Transcatheter Edge-to-Edge Repair: Lessons From Europe
7 min.
Yes, It can be already too late for TTVI !
5 min.
No, It's never too late for TTVI !
16 min.
Transjugular Tricuspid Valve Replacement Using the LUX Valve in Western China
12 min.
A Comprehensive Overview of New Transcatheter TR Therapies
8 min.
Treatment Algorithms: Matching Devices With Anatomy and Clinical Factors
9 min.
Current Clinical Evidence Following TR Interventions
20 min.
Tricuspid Valve Interventions: When Is the RV Too Sick?
8 min.
When Heterotopic TTVR is the Optimal Choice: A Series of Complex Case Examples
7 min.
Case Presentation: A Patient With Severe TR and Limited Therapeutic Options
4 min.
KEYNOTE LECTURE: The Concept of Heterotopic TTVR: Pathophysiologic and Anatomical Considerations; TRICUS and TRICAV Clinical Trial Updates
22 min.
Heterotopic TTVR Indications Are Limited, and Should Be Considered Palliative Therapy
9 min.
Are TMVR Devices Designed to Meet the Tricuspid Needs? – Technological Challenges and Opportunities for Innovation
8 min.
Emerging TTVR Solutions and Remaining Unmet Clinical Needs
26 min.
Leaflet Modification and Septal Reduction in Bioprosthetic Mitral Intervention (When and Why)
17 min.
SPOTLIGHT LECTURE: Defining the Ideal Candidate for Orthotopic TTVR - Clinical and Anatomical Considerations
17 min.
Clinical Data (and Experience) in TTVR: The Good, the Bad, and the Ugly
14 min.
TTVR Will Rapidly Become the Gold Standard of TR Treatment
8 min.
TTVR Use Will Be Reduced to a Specific Patient and Anatomical Subset!
12 min.
The VDyne TTVR System: Early Human Clinical Results
17 min.
First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)
7 min.
The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)
22 min.
First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial
13 min.
SPOTLIGHT INNOVATION LECTURE: Making the Case for TTVR and the Need for the Development of Dedicated Replacement Systems
19 min.
Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)
5 min.
First-in-Human Transfemoral Tricuspid Valve Replacement With an Innovative Transcatheter Heart Valve Replacement System (TriCares TOPAZ)
5 min.
Early Human Experience With the Venus MedTech Cardiovalve TTVR System
6 min.
Predictors of TTVR Success and Failure: Imaging and Technical Considerations
7 min.
Right-Ventricular Failure
5 min.
Thrombosis, HALT, and Bleeding Risk
5 min.
PPM Lead Dislodgement and New PPM Requirements
6 min.
Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials
8 min.
To Repair or Replace: A Treatment Algorithm Derived from Multimodality Imaging
3 min.
TCT 815: Percutaneous Mechanical Tricuspid Valve Paravalvular Leak Closure: Important Technical Considerations
5 min.
TCT 694: Debulking Tricuspid Valve Vegetations: Using AngioVac to Avoid Reoperations for Prosthetic Valve Endocarditis
6 min.
TCT 620: Valve-in-valve transcatheter tricuspid valve replacement in the patient with pacemaker-dependent complete heart block
5 min.
TCT 689: Transfemoral transcathetertricuspid valve replacement in a patient with moderate right ventricular dysfunction
6 min.
TCT 639: Technically Challenging Transcatheter Tricuspid Valve in Valve Procedure for Right Heart Failure
5 min.
Bringing Mitral Technologies to the Right: Key Physiological and Hemodynamic Differences
6 min.
From Bench to Preclinical: Key Tests and Considerations
5 min.